Community Education for Cardiovascular Disease Prevention

Size: px
Start display at page:

Download "Community Education for Cardiovascular Disease Prevention"

Transcription

1 American Journal of Epidemiology Copyright O 996 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 44, No. 4 Printed in U.S. A Community Education for Cardiovascular Disease Prevention Morbidity and Mortality Results from the Minnesota Heart Health Program Russell V. Luepker, Lennart Rastam, ' 2 Peter J. Hannan, David M. Murray, Clifton Gray, William L Baker, Richard Crow, David R. Jacobs, Jr., Phyllis L Pirie, Steven R. Mascioli, ' 3 Maurice B. Mittelmark, ' 4 and Henry Blackburn The Minnesota Heart Health Program was a community trial of cardiovascular disease prevention methods that was conducted from 980 to 990 in three Upper Midwestern communities with three matched comparison communities. A 5- to 6-year intervention program used community-wide and individual health education in an attempt to decrease population risk. A major hypothesis was that the incidence of validated fatal and nonfatal coronary heart disease and stroke in 30- to 4-year-old men and women would decline differentially in the education communities after the health promotion program was introduced. This hypothesis was investigated using mixed-model regression. The intervention effect was modeled as a series of annual departures from a linear secular trend after a 2-year lag from the start of the intervention program. In the education communities, 2,394 cases of coronary heart disease and 88 cases of stroke occurred, with 2,526 and 39 cases, respectively, being seen in the comparison communities. The overall decline in coronary heart disease incidence was.8 percent per year in men (p = 0.03) and 3.6 percent per year in women (p = 0.00). For stroke, there were no significant secular trends. The authors recently published findings showing minimal effects of sustained intervention on risk factor levels. In the current report, there was no evidence of a significant intervention effect on morbidity or mortality, either for coronary heart disease or for stroke. Am J Epidemiol 996;44: cardiovascular diseases; health education; health promotion; morbidity; mortality; primary prevention Atherosclerosis, clinically manifest as coronary heart disease and stroke, is the major cause of death and disability in many Western industrialized societies (, 2). Strong downward trends in heart disease mortality rates have been observed since the late 960s, and even longer for stroke (3,4). The improvements in heart disease mortality are associated with declining population levels of serum cholesterol, blood pressure, and cigarette smoking (5, 6), while for stroke, they are associated with declining blood pressure levels, achieved partly through better detection and treatment of hypertension (). Received for publication August 8, 995, and in final form January 2, 996. Abbreviations: MHHP, Minnesota Heart Health Program; ICD-9, International Classification of Diseases, Ninth Revision. Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN. 2 Current address: Department of Community Medicine, School of Medicine, Lund University, Malmd, Sweden. 3 Current address: American Medical Systems, Minnetonka, MN. 4 Current address: Department of Psychosocial Sciences, School of Psychology, University of Bergen, Bergen, Norway. Reprint requests to Dr. Russell V. Luepker, Division of Epidemiology, School of Public Health, University of Minnesota, 300 South Second Street, Suite 300, Minneapolis, MN A number of community trials designed to enhance these salutary disease trends have been implemented in the United States and Europe, beginning in the early 90s (8-5). Their purpose has been to develop and test interventions designed to decrease the public health burden of cardiovascular disease. A common denominator has been the use of community-wide and individual health education to influence levels of risk factors, mainly by improving eating and activity patterns and reducing smoking. All of these projects have reported mixed results with regard to risk factor changes (8-0, 6-; C. Smith, Health Promotion Wales, personal communication, 994), with more favorable outcomes being seen in the earlier studies (8-0, 6). Only the North Karelia Project has published results for morbidity and mortality (, ) during 0 years of follow-up, reporting a favorable effect of intervention on ischemic heart disease mortality (). The Minnesota Heart Health Program (MHHP) was the largest of the studies completed, and it involved six communities in Minnesota, North Dakota, and South Dakota (2). The MHHP results regarding changes in risk factor levels were recently published (); the 35

2 352 Luepker et al. changes were modest and usually within levels attributable to chance. The present paper is the final report on the main outcomes of the MHHP. It presents the results of the intervention program on morbidity and mortality from coronary heart disease and stroke in intervention communities relative to trends observed in the comparison communities. MATERIALS AND METHODS The Minnesota Heart Health Program The MHHP was a research and demonstration project conducted during the 980s ( ) and intended for primary prevention of coronary heart disease and stroke. The intervention program involved three communities in Minnesota and North Dakota with a total of approximately 0,000 inhabitants (2, ). It operated on both the individual level and the community level and was based on several theories of behavior change (-28). It developed and implemented a number of community-wide intervention approaches, including mass media campaigns (), systematic risk factor screening and education (30), changes in the environment to encourage "hearthealthy" behavior (3), and direct education of young people (), adults, and health professionals (33). The program aimed specifically at lowering population levels of blood cholesterol, blood pressure, and smoking and increasing the level of physical activity. Research design TABLE. Characteristics of the paired Intervention and comparison communities in the Minnesota Heart Health Program, Characteristic and community pair* Small rural Large rural Fargo/Moorhead Metropolitan suburban Total populatlont 3,809,053 04,63 8,484 8,95 4,83 Population aged 30-4 yaarsf 3,5 9,53 3,35,054 38,948,5 * All communities are located in Minnesota, except Fargo (North Dakota) and (South Dakota), t 980 US Census data. The research design of the MHHP has been described in detail elsewhere (). Briefly, the MHHP was a nonrandomized community trial with three community pairs (table ). For each pair, two communities were selected that were similar in terms of size, structure, and distance from Minneapolis. Within each pair, one community was chosen, not randomized, for intervention and the other for comparison. As figure shows, the intervention program began on November, 98, in, Minnesota. Twenty-two and 28 months later, respectively, it began in Fargo- Moorhead (North Dakota-Minnesota) and in, Minnesota. The program continued for 5-6 years in each community, with a transition of program coordination to local advisory boards toward the end of that period. Study endpoints Population-wide data on first events of definite coronary heart disease and stroke were used for this study, with restriction to men and women aged 30-4 years and resident in one of the six communities at the time of their event. Hospital discharge register codes (International Classification of Diseases, Ninth Revision (ICD-9) (35)) from 39 hospitals in the six communities (one small hospital declined participation) were used to identify candidate events. The candidate events were then validated with medical records by a standard protocol, summarized below. For out-of-hospital coronary heart disease, candidate events were identified from computerized mortality tapes obtained from the three state Departments of Health and then validated. Out-of-hospital stroke deaths, a small fraction of cases in the age group 30-4 years, were not systematically sought and thus were not included in the analyses. As figure shows, surveillance started in 980 or 98 in all cities and continued for 9 years in and, Minnesota; for 0 years in Fargo- Moorhead and in, South Dakota; and for years in and, Minnesota. Validation of definite coronary heart disease The diagnosis of definite coronary heart disease included both fatal and nonfatal cases and both inhospital and out-of-hospital events. It comprised four distinct categories: ) definite in-hospital myocardial infarction (fatal or nonfatal); 2) definite out-ofhospital myocardial infarction; 3) sudden cardiac death; and 4) definite fatal out-of-hospital coronary heart disease. Thus, all nonfatal cases were hospital admissions. Definite in-hospital myocardial infarction. The first category was based on abstraction of records for casepatients residing in one of the MHHP communities and discharged alive or dead from one of the participating hospitals with any of the ICD-9 codes or Events were validated on the basis of a

3 Community Education for Cardiovascular Disease Prevention Project Year Calendar Year (Education) Education Program (Comparison) Surveillance(Both Towns) Fargo-Moorhead (Education) (Comparison) Surveillance(Both Towns) (Education) Education Program (Comparison) SurveillancefBoth Towns) " Surveillance Data Includ^n Analysis ^ 3 Surveillance Data Excluded From Analysis H ^ " n ( e n s e Educa^ : : i Transittona, Period i : : g l^j H ] C o m m u n i t y Ownership ' ' FIGURE. Outline of the 2-month periods defining the baseline and education years in the Minnesota Heart Health Program communities, E-3, E-2, E-, and E0 are the baseline years, and E-E6 are the education years. Hatched areas Indicate periods with data collection and event validation that was used for definition of first events but not for the final analyses. standard approach to data on enzyme patterns and electrocardiographic recordings obtained from the medical records. The records were abstracted by trained nurse abstractors under the supervision of a physician. A prerequisite for validation as definite myocardial infarction was the availability of data on the enzymes creatinine phosphokinase or creatinine phosphokinase-myocardial band. In the absence of enzymes or the presence of a normal enzyme pattern, the case could not be classified as definite. Table 2 shows the algorithm for classification of an enzyme pattern as abnormal or equivocal for the two enzyme measures. All events with abnormal enzyme patterns were classified as definite. With an equivocal enzyme pattern, the case was classified as definite when electrocardiograms showed "evolving evidence" of myocardial infarction: a minimum of two recorded electrocardiograms with an evolving Q-wave pattern, or ST-segment depression or elevation or T-wave inversion, in the setting of equivocal Q waves. This method, which uses a special Minnesota electrocardiographic code (36), is described in detail elsewhere (3). Out-of-hospital myocardial infarction. The second TABLE 2. Algorithm used for classification of enzyme patterns in coronary heart disease cases for which data were abstracted from medical records for validation, Minnesota Heart Health Survey, CPK-MB* data missing CPK-MB <00%f or negative CPK-MB 00-99% or positive CPK-MB 0% CPK'data missing CPK <0O%t CPK 00-99% CPK io% Normal Equivocal Normal Normal Equivocal Equivocal Equivocal Equivocal * CPK, creatinine phosphokinase; CPK-MB, creatinine phosphokinase-myocardial band. t Percentage of the reference value at each hospital. Negative/positive refers to cases in which the actual CPK-MB value was not provided. Am J Epidemiol Vol. 44, No. 4, 996 J Education Program

4 354 Luepker et al. category comprised only fatal cases and was based on computerized information from the mortality registers of the three state health departments. Cases were abstracted for residents in the MHHP communities aged 30-4 years with ICD-9-code(s) 40-44, 42.5, 428, or given as the underlying cause of death on the death certificate. The diagnosis was regarded as definite either when myocardial infarction was verified by autopsy records or when informant interviews, performed 2-4 years after the death, gave evidence of hospitalization due to acute myocardial infarction during the 4 weeks before death. These interviews were performed via telephone by trained interviewers according to a strict protocol. Sudden cardiac death. The third category was also based on computerized information from the death registers. All records on age-eligible MHHP resident cases with ICD-9-code(s) 40-44, 42.5, 428, or given as the underlying cause of death were abstracted. The diagnosis was regarded as valid when the informant interview indicated that death had occurred within hour of acute cardiac symptoms or within hour of the last observation with no symptoms. Definite fatal out-of-hospital coronary heart disease. The fourth category included age-eligible MHHP resident fatal cases occurring out-of-hospital, with ICD-9 code(s) given as the underlying cause of death and an informant interview or autopsy indicating a history of myocardial infarction or severe coronary artery disease or death within - hours after the onset of symptoms. Validation of definite acute stroke For stroke, patients residing in one of the MHHP communities who were discharged from any of the participating hospitals (alive or dead) with any of the ICD-9 codes 40, 4, 430-4, 4, 436, or 43 were selected, and data were validated using information abstracted from the medical records. A case was excluded when physician findings, computerized tomography, or autopsy gave evidence of brain tumor or metastasis, epidural or subdural hematoma, subarachnoid hemorrhage, systemic embolism, or a comatose state of any other origin (e.g., hepatic, diabetic, hypoglycemic, uremic, or epileptic). Following these exclusions, a case was labeled "definite" if an autopsy demonstrated evidence of cerebral infarction or cerebral hemorrhage. When an autopsy was not performed, all three of the following criteria were required: ) a localizing neurologic deficit and/or a change in the patient's state of consciousness, with a history of rapid onset (less than 48 hours from onset to time of admission or to maximum acute neurologic deficit or death); 2) documentation of the localizing neurologic deficit by unequivocal physical or laboratory findings (computerized tomography showing evidence of either cerebral hemorrhage or cerebral infarction) within 6 weeks of the onset of symptoms; and 3) more than hours' duration of unequivocal physical findings, or findings leading to death, or death within hours after onset of symptoms. Definition of fatality Irrespective of whether a hospitalized patient was discharged ah've or dead, an event was defined as fatal if death occurred within 28 days of admission to hospital. This classification was obtained by record linkage between the MHHP case register and the state health department mortality registers. Elimination of repeat events The present study included the first event in the study period for each subject. In the case of multiple events, definite in-hospital myocardial infarction took priority over definite out-of-hospital coronary heart disease or sudden cardiac death. If, in one subject, there remained more than one in-hospital myocardial infarction, the first of those events was selected. However, one subject could contribute to both the register of definite coronary heart disease and the register of definite stroke on separate occasions for example, by having a definite stroke followed by a fatal definite coronary heart disease event. Assignment of events to baseline and education years Each validated event was assigned to a specific 2-month period based on the date of hospital admission for hospitalized cases and the date of death for nonhospitalized cases. For each pair of communities, the annual start of a new year was defined as the month in which the intervention program began in the intervention community of the pair (figure ). This gave one complete baseline year (E0) and one incomplete baseline year (0 months during E-l) in and. In Fargo-Moorhead and Sioux Falls, there were three complete baseline years (E-2, E-l, and E0) and one incomplete baseline year (8 months during E-3). Events that occurred during all of these months were used in the analyses, together with those of the four complete baseline years in and. However, the first 2 months of 980 in and were not included in the analysis.

5 Community Education for Cardiovascular Disease Prevention 355 For education years, only those years having complete data from all six communities were used. Therefore, events that occurred after November, 98, in and ; after September, 989, in Fargo-Moorhead and ; and after March, 990, in and were not used. This left six complete education years for each community pair (E-E6). Thus, E-3, E-2, E-l, and E0 were the consecutive 2-month periods before intervention began, and E-E6 were the 2-month periods of intervention. Statistical methods Rates specific to sex, community intervention, year, and 5-year age stratum were calculated as events per person-year of exposure. Population sizes in each community were taken from the US Censuses for 980 and 990, by sex and 5-year age group. Person-years of exposure by sex, age group, and community were estimated by linear interpolation of the census figures, allowing for the time offsets between baseline/education year and calendar year. Rates were standardized to the 985 age structure of all MHHP communities. Weights were assigned to each rate, reflecting the number of person-years involved. The analysis method was the same as that used with MHHP cross-sectional risk factors, and it is described in detail elsewhere (38). The mixed-model regression analysis was carried out using the MIXED procedure of the Statistical Analysis System (SAS Institute, Inc., Cary, North Carolina; version 6.09). The unit of analysis was the city-year mean, each weighted by personyears of exposure. Year and the MHHP intervention were treated as fixed effects, and community was treated as a nested random effect. A common linear secular trend was estimated from all years (including E-3 and E-2) in comparison communities and from years prior to E3 in the education communities. The MHHP intervention was represented by a series of year-specific departures from that secular trend, beginning in E3, to allow for an a priori 2-year lag postulated between any risk factor effect and an impact on morbidity and mortality. Men and women were analyzed separately. and had no data for the years E-3 and E-2. This was not a problem in the mixed-model regression analysis, but it prevented calculation of pooled education and comparison mean rates for those years without assumptions about the missing rates. For presentation of those pooled rates, shown in the lefthand panels of figures 2 and 3, we avoided assumptions and calculated weighted mean rates for only the years E-l through E6; however, to aid interpretation, we shifted the rate in each community in each year by a constant community-specific amount to equalize the weighted mean rates in the education and comparison conditions in years E-l through E2. RESULTS Coronary heart disease A total of 4,9 cases of definite coronary heart disease occurred during follow-up, 3,66 (4.4 percent) in men and,9 (.6 percent) in women. As table 3 shows, the proportion of fatal cases did not differ between men (3.9 percent) and women (36.9 percent) (p = 0.6). Among fatal events, the most striking sex difference was a higher proportion of sudden cardiac death in men (3. percent; 54/,386) than in women (.4 percent; 09/465) (p < 0.000). Of the total number of cases, 2,394 (48. percent) occurred in the education communities and 2,526 (5.3 percent) in the comparison communities. Within each community, there was large year-to-year variation in the number of events (Appendix table ). This variability is reflected in the community-, year-, and sex-specific age-adjusted yearly event rates presented in table 4. For the years when data from all communities were available, adjusted event rates for the pooled education and comparison communities are presented in the left-hand panel of figure 2. In these aggregated data, there was also large variation, but striking symmetry was seen between the two sets of communities, especially for men. Application of the mixed-model regression analysis confirmed a downward linear trend in the event rate for both men and women. The event rate for coronary heart disease decreased by.8 percent per year for men (p for slope = 0.03) and 3.6 percent per year for women {p for slope = 0.00); these secular trends are TABLE 3. Distribution of the subclasses of definite coronary heart disease and stroke among men and women, Minnesota Heart Health Survey, No. Men No. Women Nonfatal acute myocardia) infarction 2, Fatal acute myocarcfial infarction, In-hospital fatal acute myocardal infarction Out-of-hospital acute myocardal infarction Sudden candfiac death Definite fatal coronary heart disease All definite coronary heart dsease 3, , All definite stroke (in-hospital only)

6 356 Luepker et al. TABLE 4. Age-standardized rates (per 00,000 person-years]) of definite coronary heart disease (fatal and nonfatal combined) in men and women aged 30-4 years when the event occurred, Mnnesota Heart Health Program, * Education year Community E-3 E-2 E- EO E E2 E3 E4 E5 E6 Men Fargo-Moo rhead Woman Fargo-Moo rhead * The standard population was the total population aged 30-4 years in the six study communities plotted in the right-hand panel of figure 2. Also shown in figure 2 are the annual deviations from the trend observed in the three education communities, along with 95 percent confidence intervals; all of these confidence intervals overlapped the fitted secular trend, and none of the annual deviations were statistically significant. Fitted linear trends for the education communities during years E3-E6, forced through the origin at E2 (the latest point prior to the hypothesized intervention effect), had slopes that were not different from those of the unconstrained secular trends among men and women. An age-stratified analysis showed similar results, with no significant MHHP effects for ages above and below 65 years. The same was true for a subgroup analysis restricted to fatal cases. Stroke A total of,55 patients had a definite stroke; 90 strokes (58.3 percent) occurred in men and 650 (4. percent) in women (table 3). Of the total number, 88 (52.5 percent) strokes occurred in the education communities and 39 (4.5 percent) in the comparison communities. Just as for coronary heart disease, there was considerable variation between the annual numbers of events (Appendix table 2). This variability was again reflected in the community-, year-, and sex-specific age-adjusted yearly event rates presented in table 5. For the years when data from all cities were available, adjusted event rates for the intervention and comparison areas are presented in the left-hand panel of figure 3. The mixed-model regression analysis revealed no significant linear secular trends for stroke. In men, the mean annual change was a decline of 0.5 percent per year relative to the level at El (p for slope = 0.8), and in women there was an increase of 2.3 percent per year (p for slope = 0.36). Also shown in figure 3 are the annual deviations from the trend for the intervention communities, with 95 percent confidence intervals. As for coronary heart disease, all confidence intervals for stroke overlapped the fitted trend, and none of the annual deviations were statistically significant. The fitted linear trend for stroke in years E3-E6, forced through the origin at E2, did not deviate significantly from the secular trend. None of the above results changed with stratification by age. DISCUSSION This paper reports the final results of one of the most complex community trials yet conducted in cardiovascular disease prevention. To our knowledge, it is the first to provide controlled data on the possible impact of a community-wide intervention on fatal and nonfatal cardiovascular disease rates. The results are clear: There was no evidence of a significant intervention effect on morbidity or mortality, either for coronary heart disease or for stroke. This is not surprising, given the recently published risk factor findings from the MHHP () and given the strong and favorable secular trends in coronary heart disease risk with which the intervention program had to compete. We recently reported that the MHHP had only modest effects on population risk factor levels (). That report also documented the strong, 2-3 percent annual decline in a coronary heart disease risk

7 Community Education for Cardiovascular Disease Prevention 35 POOLED AND AGE-STANDARDIZED EVENT RATES FITTED SECULAR TREND AND MHHP EFFECT ESTIMATES 500" Male* " c^- 400" EDUCATION YEAR EDUCATION COMMUNTTES COMPARISON COMMUNmES o- T ~~~ - =LJ i r EDUCATION YEAR - EDUCATION EFFECT, I 95% CONFIDENCE BOUNDS SECULAR TREND FIGURE 2. Effect of a community education program on definite coronary heart disease rates among 30- to 4-year-old men and women in the Minnesota Heart Health Program (MHHP), All results are standardized to the mean population of subjects aged 30-4 years in the study communities. Left panel: Age-standardized event rates, pooled between communities using numbers of personyears In each community as weights. The rates were adjusted to provide a common mean level between educated and comparison communities during baseline and lag periods (E- through E2). Right panel: Fitted secular trend and annual MHHP effect estimates; bars, 95% confidence intervals. score for comparison communities (39, 40) during the MHHP intervention period. In the MHHP, the annual decline in coronary heart disease event rates in comparison communities was.8 percent in men and 3.6 percent in women. Both slopes were statistically significant. This corresponds to an accumulated decrease during the 4 years of observation (E2-E6) of.2 percent in men and 4.4 percent in women. It now seems unlikely that a project using local methods of public education would be able to augment this significant background trend over such a short period. Such trends were not anticipated when the MHHP was designed in the late 90s. In contrast, secular trends in stroke were less striking. While stroke mortality continued to decline nationally during the 980s, it plateaued in the Minnesota Heart Survey communities (Minneapolis-St. Paul) from 980 to 990 (). National data on stroke morbidity during the same interval are lacking, but the Minneapolis-St. Paul age-adjusted in-hospital event rate for stroke declined from 980 to 985, from,03 to 988 per 00,000 male inhabitants and from 926 to 804 in women (). Simultaneously, the proportion of in-hospital definite stroke (validated as in the MHHP) increased from 43 percent to 50 percent in men and from 4 percent to 5 percent in women (). Together, the Minnesota Heart Survey data indicate no trend in the definite stroke rate in men and an increase of about 2.5 percent per year in women. The pattern corresponds well with the observations of the MHHP. One possible reason for this break in the continuous decline in stroke incidence is ascertainment bias due to increasing use of computerized tomography (). Therefore, it is possible that the MHHP intervention was competing with downward population trends in stroke incidence as well. The fact that the MHHP was unable to demonstrate improved prevention of first stroke was also expected in view of the intervention's limited impact on average blood pressure levels in the education communities relative to the reference communities notably on the

8 358 Luepker et al. TABLE 5. Age-standardized rates (per 00,000 person-years) of definite in-hospital stroke (fatal and nonfatal combined) In men and women aged 30-4 years when the event occurred, Minnesota Heart Health Program, * Education year Community E-3 E-2 E- E0 E E2 E3 E4 E5 E6 Men Fargo-Moorhead Women Fargo-Moorhead * The standard population was the total population aged 30-4 years in the six study communities prevalence of treatment for hypertension and on blood pressure levels in treated patients (, 4). The North Karelia Project published morbidity data for the first 5 years of intervention (), but the design was not controlled, and in view of the strong secular trends in Finland, the findings are not conclusive of an intervention effect. The Finnish investigators have continued to compare coronary heart disease mortality rates in North Karelia with those in the reference community and in all of Finland. They demonstrated more rapidly declining rates during the first years in the intervention community than in these reference populations (). The North Karelia Project may have achieved some acceleration of a strong secular trend, but whether this should be attributed to the intervention program has been questioned (42). There were also fundamental differences in the circumstances in which the North Karelia Project and the MHHP were conducted. The Finnish project was instituted in 92 in a part of Europe that had some of the highest coronary heart disease rates in the world, with the levels of related risk factors being extremely high. The MHHP, on the other hand, involved populations at or below the average risk of populations in other industrialized countries. Thus, while there were downward secular trends in both areas, the rates moved from extremely high to high in North Karelia while staying within the medium range in Minnesota. The MHHP was started 0-2 years later than the Finnish study, when interest in coronary heart disease prevention in clinical medicine and the mass media was already high. In the United States, the National High Blood Pressure Education Program (43) was well along, and the National Cholesterol Education Campaign (44) had begun. For many years, Minnesota also had an integrated program of legislation regarding the control of smoking in public areas. Thus, Minnesota was already in an accelerated phase of risk reduction when the MHHP began. These differences may well be the most important reasons for the difference in outcome from the Finnish project. Neither the North Karelia Project nor the MHHP appeared to have any impact on stroke rates. This may be a consequence of the relatively lesser emphasis placed on a high-risk approach. An aggressive program for identification and treatment of hypertension can influence the incidence of stroke in the population, as was recently demonstrated in a Swedish trial (45). Other community trials have reported effects on risk factor levels. Favorable results were described by the Stanford Five-City Project (8) and the German Cardiovascular Prevention Study (4), while the Pawtucket Heart Health Program (2) and the Heartbeat Wales Programme (C. Smith, Health Promotion Wales, personal communication, 994) had ambiguous results similar to those of the MHHP. The cardiovascular event rates of these studies have not yet been reported at diis writing. Methodological considerations Several methodological issues warrant further consideration. First, hospital morbidity data and death certificate data became available annually, and this created a mismatch between those data and the MHHP education schedule, leaving incomplete years at the end of the MHHP (figure ). We considered using the rates from all partial years, weighting by person-years of exposure. However, in the presence of a measurable trend, this procedure would lead to bias in the full-year

9 Community Education for Cardiovascular Disease Prevention 359 POOLED AND AGE-STANDARDIZED EVENT RATES FITTED SECULAR TREND AND MHHP EFFECT ESTIMATES / 4 y " 40- Mate Females T~ < -^ EDUCATION YEAR EDUCATION COUHUNTTES COMPARISON COMMUNITIES " o- I I EDUCATION YEAR EDUCATION EFFECT, 95% CONFIDENCE BOUNDS SECULAR TREND FIGURE 3. Effect of a community education program on definite in-hospital stroke rates among 30- to 4-year-old men and women in the Minnesota Heart Health Program (MHHP), All results are standardized to the mean population of subjects aged 30-4 years in the study communities. Left panel: Age-standardized event rates, pooled between communities using numbers of person-years in each community as weights. The rates were adjusted to provide a common mean level between educated and comparison communities during baseline and lag periods (E- through E2). Right panel: Fitted secular trend and annual MHHP effect estimates; bars, 95% confidence intervals. estimates, and further bias would arise from the shifting relative contribution of each pair in those partial years. We chose to use data weighted by person-years only if the partial year included at least 8 months of data for each of the two largest pairs. Second, only events validated as definite were used to calculate rates, although other events were recorded as possible events when they did not meet the full criteria for definite coronary heart disease or stroke. Because a combined analysis of definite plus possible events showed virtually the same results as those presented here, we limited this presentation to definite events. There are also two issues related to the regression analysis we used. We conducted analysis at the community level, fitting a regression model to the agestandardized annual rates from the six MHHP communities. Such an analysis is appropriate, given the allocation of intact communities to the intervention and comparison groups, and has been widely recommended (46-50). However, a common concern with such analyses is their low statistical power. In planning the study, we had projected 85 percent power to detect net differences in coronary heart disease mortality of 5- percent over 6 years, based on an analysis of men and women pooled, comparing the three intervention communities with the entire states of Minnesota, North Dakota, and South Dakota. The detectable difference for stroke mortality had been estimated to be about 35 percent over a 6-year period. As the analysis progressed, it became clear that the effects were different in men and women, such that pooling no longer made sense. In addition, as the modest differences emerged, it also became clear that there was little point in comparing the intervention communities with the three states, particularly when that analysis would be restricted to deaths based on unvalidated state death tapes. We knew that statistical power would be reduced for sex-specific analyses comparing the education and comparison communities alone. Now we believe that these analyses are more informative than those origi-

10 360 Luepker et al. nally envisioned. Given 80 percent statistical power and based on observed variations in the data, the detectable net differences over 5 years for coronary heart disease and stroke in the analyses reported here were 28.3 percent and 58.3 percent, respectively, for men and 49.6 percent and 62. percent, respectively, for women. While the power to detect 5- percent net differences was well below 85 percent, we do not attribute the results reported here to low power. Rather, they appear to be due to a lack of substantial, lasting differences between the intervention and comparison communities in levels of coronary heart disease risk factors and subsequent morbidity and mortality. In addition, the regression analysis assumed a common linear secular trend. This is important, because the imposition of a linear trend influenced the MHHP intervention effect estimates computed as yearspecific departures from that trend. A comparison of the left- and right-hand panels in figures 2 and 3 confirms that the model fitted the data reasonably well for stroke but less well for coronary heart disease. A paired-difference model would have avoided this problem, but it would have provided considerably less power (only df), would not have estimated the secular trend, and would have substituted one set of assumptions for another. Because any model is an imperfect simplification of the underlying data, we have shown both the left- and right-hand panels in figures 2 and 3, as well as the age-standardized rates presented in tables 4 and 5, to assist the reader in interpreting these results. Finally, we acknowledge that randomization was not employed in the MHHP design. Given the few communities in the study, simple randomization had little likelihood of achieving comparability between the intervention and comparison areas. More recent trials have used a greater number of units (5); under these conditions, randomization has a greater Likelihood of achieving comparability between intervention and comparison areas. In the MHHP, adjustment was possible for some baseline characteristics that should have been balanced by randomization (sex and age distributions and disease incidence rates). Other characteristics of the communities that were potentially important to the outcome (e.g., educational level) could not be considered. Conclusions The Minnesota Heart Health Program was launched during a decade of strongly declining secular trends in cardiovascular disease risk in Minnesota and nationally. Although individual elements of the intervention programs had the effects intended (30-33), the program as a whole did not accelerate risk reduction beyond those trends. However, the MHHP, along with related programs in California () and Rhode Island (3), has influenced national programs and policies. That may, in turn, have influenced the comparison communities in these studies as well as the national trends. Many reports have appeared on the success of individual intervention efforts within the framework of the community projects, and those publications have probably served as a stimulus for other investigators and policy-makers. The problems involved in conducting large-scale community trials are widely acknowledged today (52, 53). Investigators should benefit from this experience in planning future study designs and interventions. ACKNOWLEDGMENTS This research was supported by a grant from the National Heart, Lung, and Blood Institute (RO HL 5). Dr. Rastam was supported by grants from the Swedish Medical Research Council, the Swedish Society of Medicine, and the Johan and Henning Throne Hoist Foundation. The authors acknowledge the many staff who worked in the MHHP and the cooperation of the citizens of the six study communities. REFERENCES. Keys A, ed. Coronary heart disease in seven countries. Dallas, TX: American Heart Association, 90. (American Heart Association monograph no. ). 2. World Health Organization. World health statistics annual. Geneva, Switzerland: World Health Organization, Stamler J. The marked decline in coronary heart disease mortality rates in the United States, : summary of findings and possible explanations. Cardiology 985;2: Whisnant JP. The decline of stroke. Stroke 984;5: Burke GL, Sprafka JM, Folsom AR, et al. Trends in CHD mortality, morbidity and risk factor levels from 960 to 986: The Minnesota Heart Survey. Int J Epidemiol 989;8(suppl ):S3-S8. 6. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 994;309:-.. McGovem PG, Burke GL, Sprafka M, et al. Trends in mortality, morbidity, and risk factor levels for stroke from 960 through 990: The Minnesota Heart Survey. JAMA 992;268: Farquhar JW, Maccoby N, Wood PD, et al. Community education for cardiovascular health. Lancet 9;: Puska P, Toumilehto J, Salonen J, et al. The North Karelia Project: community control of cardiovascular disease. Evaluation of a comprehensive community programme for control of cardiovascular diseases in 92-9 in North Karelia, Finland. Copenhagen, Denmark: World Health Organization, Gutzwiller F, Nater B, Martin J. Community-based primary prevention of cardiovascular disease in Switzerland: methods and results of the National Research Program (NRP A). Prev Med 985;4:482-9.

11 Community Education for Cardiovascular Disease Prevention 36. Farquhar JW, Fortmann SP, Maccoby N, et al. The Stanford Five-City Project: design and methods. Am J Epidemiol 985; : Mittelmark MB, Luepker RV, Jacobs DR, et al. Communitywide prevention of cardiovascular disease: education strategies of the Minnesota Heart Health Program. Prev Med 986; 5:-. 3. Elder JP, McGraw SA, Abrams DB, et al. Organizational and community approaches to community-wide prevention of heart disease: the first two years of the Pawtucket Heart Health Program. Prev Med 986;5: GCP Study Group. The German Cardiovascular Prevention Study (GCP): design and methods. Eur Heart J 988;9: Nutbeam D, Catford J. The Welsh Heart Health Programme evaluation strategy: progress, plans and possibilities. Health Promotion 98;2: Salonen JT, Puska P, Kottke TE, et al. Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program: The North Karelia Project. Am J Epidemiol 98;4: Puska P, Salonen JT, Nissinen A, et al. Change in risk factors for coronary heart disease during 0 years of a community intervention programme (North Karelia Project). Br Med J 983;28: Puska P, Toumilehto J, Nissinen A, et al. The North Karelia Project: 5 years of community-based prevention of coronary heart disease. Ann Med 989;2: Farquhar JW, Fortmann SP, Flora JA, et al. Effects of communitywide education on cardiovascular disease risk factors: The Stanford Five-City Project JAMA 990;264: Luepker RV, Murray DM, Jacobs DR Jr, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health 994;84: Carleton R, Lasater TM, Assaf AR, et al. The Pawtucket Heart Health Program: cross-sectional results from a community intervention trial. (Abstract). Circulation 994;89:9.. Greiser E, Hoffmeister H, Hoeltz J, et al. Final risk factor changes after years of a multicenter community intervention program: The German Cardiovascular Prevention Study (GCP). (Abstract). Circulation 994;89:933.. Salonen JT, Puska P, Mustaniemi H. Changes in morbidity and mortality during comprehensive community programme to control cardiovascular diseases during 92- in North Karelia. Br Med J 99;2: Tuomilehto J, Geboers J, Salonen JT, et al. Decline in cardiovascular mortality in North Karelia and other parts of Finland. BrMedJ 986;3: Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice-Hall, Inc, Hovland CI, Janis IL, Kelley HH. Communication and persuasion: psychological studies of opinion change. New Haven, CT: Yale University Press, McGuire WJ. Persuasion, resistance and attitude change. In: DeSola I, Schramm W, eds. Handbook of communication. Chicago, IL: Rand-McNally and Company, 93: Rothman J. Three models of community organization practice. In: Cox FM, Erlich JL, Rothman J, et al, eds. Strategies of community organization: a book of readings. Itasca, IL: FE Peacock Publishers, 90:-36.. Viswanath K, Finnegan JR, Hannan P, et al. Health and knowledge gaps: some lessons from the Minnesota Heart Health Program. Am Behav Scientist 99;: Murray DM, Luepker RV, Pirie PL, et al. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Prev Med 986; 5: Glantz K, Mullis RM. Environmental interventions to promote healthy eating: a review of models, programs and evidence. Health Educ Q 988;5: Perry CL, Klepp KI, Sillers C. Community-wide strategies for cardiovascular health: the Minnesota Heart Health Program youth program. Health Educ Res 989;4: Mittelmark MB, Luepker RV, Grimm R Jr, et al. The role of physicians in a community-wide program for prevention of cardiovascular disease: The Minnesota Heart Health Program. Public Health Rep 988; 03: Jacobs DR Jr, Luepker RV, Mittelmark M, et al. Communitywide prevention strategies: evaluation design of the Minnesota Heart Health Program. J Chronic Dis 986;39: World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Vol. Geneva, Switzerland: World Health Organization, Rose GA, Blackburn H. Cardiovascular survey methods. Geneva, Switzerland: World Health Organization, 968. (WHO Monograph Series no. 56). 3. Mascioli SR, Jacobs DR Jr, Kottke TE. Diagnostic criteria for hospitalized acute myocardial infarction: the Minnesota experience. Int J Epidemiol 989;8: Murray DM, Hannan PJ, Jacobs DR, et al. Assessing intervention effects in the Minnesota Heart Health Program. Am J Epidemiol 994;39: Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 96;: Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis 98;40: Rfistam L, Hannan PJ, Jacobs DR Jr, et al. Population and physician behavior and blood pressure trends: The Minnesota Heart Health Program (MHHP). (Abstract). Circulation 994; 89: Salonen JT. Did the North Karelia project reduce coronary mortality? (Letter). Lancet 98;2: US National Heart and Lung Institute. National Conference on High Blood Pressure Education. Bethesda, MD: National Heart and Lung Institute, 93. (DHEW publication no. (NIH) 3-486). 44. Lenfant C. A new challenge for America: The National Cholesterol Education Program. Circulation 986;3: Lindblad U, RAstam L, Ryd6n L, et al. Reduced stroke incidence with structured hypertension care: The Skaraborg Hypertension Project. J Hypertens 990;8: Zucker DM. An analysis of variance pitfall: the fixed effects analysis in a nested design. Educ Psychol Meas 990;50: Koepsell TD, Martin DC, Diehr PH, et al. Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs: a mixed-model analysis of variance approach. J Clin Epidemiol 99 ;44: Murray DM, McKinlay SM, Martin D, et al. Design and analysis issues in community trials. Eval Rev 994; 8: Donner A, Klar N. Cluster randomization trials in epidemiology: theory and application. J Stat Plann Inference (in press). 50. Murray DM. Design and analysis of community trials: lessons from the Minnesota Heart Health Program. Am J Epidemiol 995;42: Gail MH, Byar DP, Pechacek TF, et al. Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Controlled Clin Trials 992;3: Blackburn H. Community programs in coronary heart disease prevention and health promotion: changing community behavior. In: Marmot MG, Elliott P, eds. Coronary heart disease epidemiology: from aetiology to public health. New York, NY: Oxford University Press, 992: Winkleby MA. The future of community-based cardiovascular disease intervention studies. (Editorial). Am J Public Health 994;84:369-2.

12 362 Luepker et al. APPENDIX TABLE. Numbers of definite coronary heart disease event* (fatal and nonfatal combined) in men and women aged 30-4 years when the event occurred, Minnesota Heart Health Program, Education year Community E-3 E-2 E- EO E E2 E3 E4 E5 E6 Men Fargo-Moorhead Woman Fargo-Moorhead * During a 0-month period, t During an 8-month period. 4f 3f 8 9 lit 2f APPENDIX TABLE 2. Numbers of definite stroke events (fatal and nonfatal combined) in men and women aged 30-4 years when the event occurred, Minnesota Heart Hearth Program, Man Fargo-Moorhead Women Fargo-Moorhead Community * During a 0-month period, t During an 8-month period. E-3 2f t lit 2f E * 9* * 2* 30 3 E- 5* 9* * 5* EO Education year E E E E E E

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke International Task Force for Prevention Of Coronary Heart Disease Clinical management of risk factors of coronary heart disease and stroke Economic analyses of primary prevention of coronary heart disease

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland

Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland Public Health Medicine 2002; 4(1):5-7 Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland Pekka Puska Abstracts The paper describes the experiences

More information

Is the Apparent Cardioprotective Effect of Recent Alcohol Consumption Due to Confounding by Prodromal Symptoms?

Is the Apparent Cardioprotective Effect of Recent Alcohol Consumption Due to Confounding by Prodromal Symptoms? American Journal of Epidemiology Copyright 2000 by The Johns Hopkfns University School of Hygiene and Public Health Allrightsreserved Vol. 151, No. 12 Printed In USA. Is the Apparent Cardioprotective Effect

More information

TEXAS TOBACCO PREVENTION INITIATIVE

TEXAS TOBACCO PREVENTION INITIATIVE TEXAS TOBACCO PREVENTION INITIATIVE MEDIA CAMPAIGN AND COMMUNITY PROGRAM EFFECTS AMONG CHILDREN AND ADULTS Prepared by the Center for Health Promotion and Prevention Research at the University of Texas

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Malmö University Hospital Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 31 Dec 2008 * Report: 21 June 2010

More information

The American Cancer Society Cancer Prevention Study I: 12-Year Followup

The American Cancer Society Cancer Prevention Study I: 12-Year Followup Chapter 3 The American Cancer Society Cancer Prevention Study I: 12-Year Followup of 1 Million Men and Women David M. Burns, Thomas G. Shanks, Won Choi, Michael J. Thun, Clark W. Heath, Jr., and Lawrence

More information

Guide to Biostatistics

Guide to Biostatistics MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Skåne University Hospital, Malmö Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 30

More information

Malmö Preventive Project. Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints Malmö Preventive Project Department of Clinical Sciences Skåne University Hospital, Malmö Lund University Malmö Preventive Project Cardiovascular Endpoints End of follow-up: 30 June 2009 Report: 7 October

More information

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:

More information

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention Robert B. Wallace, MD, MSc Departments of Epidemiology and Internal Medicine University of Iowa College of Public Health

More information

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine More action needed Overview Growing burden of chronic diseases

More information

Randomized trials versus observational studies

Randomized trials versus observational studies Randomized trials versus observational studies The case of postmenopausal hormone therapy and heart disease Miguel Hernán Harvard School of Public Health www.hsph.harvard.edu/causal Joint work with James

More information

Cardiovascular Endpoints

Cardiovascular Endpoints The Malmö Diet and Cancer Study Department of Clinical Sciences Malmö University Hospital Lund University The Malmö Diet and Cancer Study CV-cohort Cardiovascular Endpoints End of follow-up: 31 Dec * Report:

More information

Independent Contribution of Electrocardiographic Abnormalities to Risk of Death from Coronary Heart Disease, Cardiovascular Diseases and All Causes

Independent Contribution of Electrocardiographic Abnormalities to Risk of Death from Coronary Heart Disease, Cardiovascular Diseases and All Causes Independent Contribution of Electrocardiographic Abnormalities to Risk of Death from Coronary Heart Disease, Cardiovascular Diseases and All Causes Findings of Three Chicago Epidemiologic Studies BLANCO

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Coronary Heart Disease (CHD) Brief

Coronary Heart Disease (CHD) Brief Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs

More information

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University

More information

African Americans & Cardiovascular Diseases

African Americans & Cardiovascular Diseases Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age

More information

Population-based Study of Unintentional Injuries in the Home

Population-based Study of Unintentional Injuries in the Home American Journal of Epidemiology Copyright 1966 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 144, Printed In U.SA Population-based Study of Unintentional

More information

Swedish Initiative for Research on Microdata in the Social And Medical Sciences

Swedish Initiative for Research on Microdata in the Social And Medical Sciences Swedish Initiative for Research on Microdata in the Social And Medical Sciences www.simsam.nu GOCARTS Kardiovaskulär epidemiologi hjärtinfarkt och stroke www.registerforskning.se GOCARTs (Gothenburg CArdiovascular

More information

Exercise Answers. Exercise 3.1 1. B 2. C 3. A 4. B 5. A

Exercise Answers. Exercise 3.1 1. B 2. C 3. A 4. B 5. A Exercise Answers Exercise 3.1 1. B 2. C 3. A 4. B 5. A Exercise 3.2 1. A; denominator is size of population at start of study, numerator is number of deaths among that population. 2. B; denominator is

More information

Risk Factors for Alcoholism among Taiwanese Aborigines

Risk Factors for Alcoholism among Taiwanese Aborigines Risk Factors for Alcoholism among Taiwanese Aborigines Introduction Like most mental disorders, Alcoholism is a complex disease involving naturenurture interplay (1). The influence from the bio-psycho-social

More information

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,

More information

Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us

Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us Ellen Løkkegaard, Clinical Associate Professor, Ph.d. Dept. Obstetrics and Gynecology. Hillerød Hospital, University of Copenhagen

More information

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden 596500SJP0010.1177/1403494815596500B. Järvholm and A. BurdorfAsbestos ban reduces mesothelioma incidence research-article2015 Scandinavian Journal of Public Health, 1 7 Original Article Emerging evidence

More information

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,

More information

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit The Centers for Medicare & Medicaid Services' Office of Research, Development, and Information (ORDI) strives to make information available to all. Nevertheless, portions of our files including charts,

More information

Telemedicine in the Prevention and Monitoring of Heart Disease

Telemedicine in the Prevention and Monitoring of Heart Disease Telemedicine in the Prevention and Monitoring of Heart Disease Prof. Dr. med. Friedrich Köhler 26. April 2012 Charité-Universitätsmedizin Berlin Facts Founded in 1710 11 Nobel laureates 12.922 employees

More information

Appendix: Description of the DIETRON model

Appendix: Description of the DIETRON model Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough

More information

Albumin and All-Cause Mortality Risk in Insurance Applicants

Albumin and All-Cause Mortality Risk in Insurance Applicants Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH

More information

Success factors in Behavioral Medicine

Success factors in Behavioral Medicine Success factors in Behavioral Medicine interventions post myocardial infarction Depression Gunilla post myocardial Burell, PhD infarction Department of Public Health, Uppsala University, Sweden XIII Svenska

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Statins and Risk for Diabetes Mellitus. Background

Statins and Risk for Diabetes Mellitus. Background Statins and Risk for Diabetes Mellitus Kevin C. Maki, PhD, FNLA Midwest Center for Metabolic & Cardiovascular Research and DePaul University, Chicago, IL 1 Background In 2012 the US Food and Drug Administration

More information

COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N.

COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N. ISSN 1744-6783 COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N. Tanaka Business School Discussion Papers: TBS/DP05/39 London: Tanaka Business School, 2005 1 Cost of skin cancer in

More information

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study European Journal of Clinical Investigation (2007) 37, 925 932 DOI: 10.1111/j.1365-2362.2007.01888.x Blackwell Publishing Ltd Review Assessing risk of myocardial infarction and stroke: new data from the

More information

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity

More information

Impact of a nurse telephone intervention among high cardiovascular risk health fair participants. Lisa H. Jensen, BSN, RN Colorado Prevention Center

Impact of a nurse telephone intervention among high cardiovascular risk health fair participants. Lisa H. Jensen, BSN, RN Colorado Prevention Center Impact of a nurse telephone intervention among high cardiovascular risk health fair participants Lisa H. Jensen, BSN, RN Colorado Prevention Center Co-authors Bonnie Leaman-Castillo PhD, Behavioral Scientist

More information

Community Intervention Trial for Smoking Cessation: Development of the Intervention

Community Intervention Trial for Smoking Cessation: Development of the Intervention Chapter 4 Community Intervention Trial for Smoking Cessation: Development of the Intervention William R. Lynn, Beti Thompson, and Terry F. Pechacek INTRODUCTION The Community Intervention Trial for Smoking

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

NEW ZEALAND INJURY PREVENTION STRATEGY SERIOUS INJURY OUTCOME INDICATORS

NEW ZEALAND INJURY PREVENTION STRATEGY SERIOUS INJURY OUTCOME INDICATORS NEW ZEALAND INJURY PREVENTION STRATEGY SERIOUS INJURY OUTCOME INDICATORS 166 MOTOR VEHICLE CRASHES IN NEW ZEALAND 2012 CONTENTS TABLES Table 1 New Zealand Injury Prevention Strategy serious outcome indicators

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal 1. STUDY TITLE: Longitudinal Assessment of Chronic Health Conditions: The Aging of Childhood Cancer Survivors 2. WORKING GROUP AND INVESTIGATORS:

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota Data Management Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota None Disclosures Objectives History of data management in medicine Review of data management

More information

BMC Med 7/19/2007; Simvastatin linked to reduced incidence of dementia, Parkinson s disease.

BMC Med 7/19/2007; Simvastatin linked to reduced incidence of dementia, Parkinson s disease. March 3, 2012 BD Response to FDA statement regarding Statins The Food and Drug Administration announced on Tuesday (February 28, 2012) the changes to the safety information on the labels of statins regarding

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

Non-response bias in a lifestyle survey

Non-response bias in a lifestyle survey Journal of Public Health Medicine Vol. 19, No. 2, pp. 203-207 Printed in Great Britain Non-response bias in a lifestyle survey Anthony Hill, Julian Roberts, Paul Ewings and David Gunnell Summary Background

More information

Case-Control Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Case-Control Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Cardiovascular Disease in Diabetes

Cardiovascular Disease in Diabetes Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality

More information

T he first Whitehall study of British civil servants, begun in

T he first Whitehall study of British civil servants, begun in 922 RESEARCH REPORT Change in health inequalities among British civil servants: the Whitehall II study J E Ferrie, M J Shipley, G Davey Smith, S A Stansfeld, M G Marmot... J Epidemiol Community Health

More information

Economic development and traffic accident mortality in the industrialized world, 1962 1990

Economic development and traffic accident mortality in the industrialized world, 1962 1990 International Epidemiological Association 2000 Printed in Great Britain International Journal of Epidemiology 2000;29:503 509 Economic development and traffic accident mortality in the industrialized world,

More information

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

incidence of coronary heart disease and occur in persons aged 65 and older; yet disease for middle-aged white males; little

incidence of coronary heart disease and occur in persons aged 65 and older; yet disease for middle-aged white males; little HEARTBEAT Cardiovascular Health Study Spring 1993 Special Issue To our CHS participants: Many of you are now in your fourth year as participants in the Cardiovascular Health Study. The time and energy

More information

HES: Deaths within 30 days of a hospital procedure or of an emergency admission to hospital - Financial year 2010-2011

HES: Deaths within 30 days of a hospital procedure or of an emergency admission to hospital - Financial year 2010-2011 HES: Deaths within 30 days of a hospital procedure or of an emergency admission to hospital - Financial year 2010-2011 Copyright 2013, The Health and Social Care Information Centre. All Rights Reserved.

More information

Alcohol Facts and Statistics

Alcohol Facts and Statistics Alcohol Facts and Statistics Alcohol Use in the United States: Prevalence of Drinking: In 2012, 87.6 percent of people ages 18 or older reported that they drank alcohol at some point in their lifetime;

More information

Design and principal results

Design and principal results International Task Force for Prevention Of Coronary Heart Disease Coronary heart disease and stroke: Risk factors and global risk Slide Kit 1 (Prospective Cardiovascular Münster Heart Study) Design and

More information

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7

More information

Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health

Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health Introduction Reader (Statistics and Epidemiology) Research team epidemiologists/statisticians/phd students Primary care

More information

No. 125 April 2001. Enhanced Surveillance of Maternal Mortality in North Carolina

No. 125 April 2001. Enhanced Surveillance of Maternal Mortality in North Carolina CHIS Studies North Carolina Public Health A Special Report Series by the 1908 Mail Service Center, Raleigh, N.C. 27699-1908 www.schs.state.nc.us/schs/ No. 125 April 2001 Enhanced Surveillance of Maternal

More information

Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011

Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011 Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 TREATMENT OF ACUTE ISCHEMIC STROKE (AIS) 1. PURPOSE: This Veterans Health Administration (VHA)

More information

Executive Summary EXECUTIVE SUMMARY

Executive Summary EXECUTIVE SUMMARY Executive Summary EXECUTIVE SUMMARY Purpose of the plan: To chart a course for the Centers for Disease Control and Prevention (CDC) and collaborating public health agencies, with all interested partners

More information

At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention?

At what coronary risk level is it cost-effective to initiate cholesterol lowering drug treatment in primary prevention? European Heart Journal (2001) 22, 919 925 doi:10.1053/euhj.2000.2484, available online at http://www.idealibrary.com on At what coronary risk level is it cost-effective to initiate cholesterol lowering

More information

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work.

on a daily basis. On the whole, however, those with heart disease are more limited in their activities, including work. Heart Disease A disabling yet preventable condition Number 3 January 2 NATIONAL ACADEMY ON AN AGING SOCIETY Almost 18 million people 7 percent of all Americans have heart disease. More than half of the

More information

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD 1 Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD Executive Summary: The presence of low urine creatinine at insurance testing is associated with increased

More information

A list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.

A list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

Chapter 2: Health in Wales and the United Kingdom

Chapter 2: Health in Wales and the United Kingdom Chapter 2: Health in Wales and the United Kingdom This section uses statistics from a range of sources to compare health outcomes in Wales with the remainder of the United Kingdom. Population trends Annual

More information

THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES. Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan. stern@umich.

THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES. Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan. stern@umich. THE RISK DISTRIBUTION CURVE AND ITS DERIVATIVES Ralph Stern Cardiovascular Medicine University of Michigan Ann Arbor, Michigan stern@umich.edu ABSTRACT Risk stratification is most directly and informatively

More information

Methods in Community-based Intervention Trials Atienza and King Community-based Health Intervention Trials: An Overview of Methodological Issues

Methods in Community-based Intervention Trials Atienza and King Community-based Health Intervention Trials: An Overview of Methodological Issues Epidemiologic Reviews Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 24, No. 1 Printed in U.S.A. Methods in Community-based Intervention Trials Atienza and

More information

The Widening Mortality Gap Between Rheumatoid Arthritis Patients and the General Population

The Widening Mortality Gap Between Rheumatoid Arthritis Patients and the General Population ARTHRITIS & RHEUMATISM Vol. 56, No. 11, November 2007, pp 3583 3587 DOI 10.1002/art.22979 2007, American College of Rheumatology The Widening Mortality Gap Between Rheumatoid Arthritis Patients and the

More information

Program Approved by AoA, NCOA. Website: www.homemeds.org

Program Approved by AoA, NCOA. Website: www.homemeds.org MEDICATION MANAGEMENT IMPROVEMENT SYSTEM: HomeMeds SM The HomeMeds SM system is a collaborative approach to identifying, assessing, and resolving medication problems in community-dwelling older adults.

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information

Diabetes Complications

Diabetes Complications Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation

More information

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES

PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES Why should mood difficulties in individuals with a health condition be addressed? Many people with health conditions also experience mood difficulties

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:

More information

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs The Role of Insurance in Providing Access to Cardiac Care in Maryland Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs Heart Disease Heart Disease is the leading cause of death

More information

Butler Memorial Hospital Community Health Needs Assessment 2013

Butler Memorial Hospital Community Health Needs Assessment 2013 Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community

More information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data

More information

The Economic Benefit of Public Funding of Insulin Pumps in. New Brunswick

The Economic Benefit of Public Funding of Insulin Pumps in. New Brunswick The Economic Benefit of Public Funding of Insulin Pumps in New Brunswick Introduction Diabetes is a chronic, often debilitating and sometimes fatal disease, in which the body either cannot produce insulin

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency London, 19 July 2007 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR

More information

The rate of hospitalizations due to assaultive injuries by spouse or partner (E976.3) per 100,000 females (13 and over)

The rate of hospitalizations due to assaultive injuries by spouse or partner (E976.3) per 100,000 females (13 and over) Domestic Violence DOMESTIC VIOLENCE TEMPLATE INDICATOR: Hospitalizations of Females Ages 13 and Over Due to Assaultive Injuries by Spouse or Partner DEFINITION: The rate of hospitalizations due to assaultive

More information

Unexpected Natural Death among Korean Workers

Unexpected Natural Death among Korean Workers J Occup Health 1999; 41: 238 243 Journal of Occupational Health Unexpected Natural Death among Korean Workers Jungsun PARK 1, Young-Sook CHO 1, Kwan-Hyung YI 1, Kyung-Yong RHEE 1, Yangho KIM 2 and Young-Hahn

More information

Stress is linked to exaggerated cardiovascular reactivity. 1) Stress 2) Hostility 3) Social Support. Evidence of association between these

Stress is linked to exaggerated cardiovascular reactivity. 1) Stress 2) Hostility 3) Social Support. Evidence of association between these Psychosocial Factors & CHD Health Psychology Psychosocial Factors 1) Stress 2) Hostility 3) Social Support Evidence of association between these psychosocial factors and CHD Physiological Mechanisms Stress

More information

STROKE April 2011 Dr Amer Jafar A delay in recognizing early warning signs (WS) and risk factors (RF) of ischemic stroke causes a delay in treatment Evaluated: knowledge of RF and WS and the impact of

More information

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Estimating the Completeness of Physician Billing Claims for Diabetes Case Ascertainment

Estimating the Completeness of Physician Billing Claims for Diabetes Case Ascertainment Estimating the Completeness of Physician Billing Claims for Diabetes Case Ascertainment Lisa M. Lix, Xue Yao, George Kephart, Khokan Sikdar, Hude Quan, J. Paul Kuwornu, Wilfrid Kouokam, Mark Smith IHDLN

More information

What are the PH interventions the NHS should adopt?

What are the PH interventions the NHS should adopt? What are the PH interventions the NHS should adopt? South West Clinical Senate 15 th January, 2015 Debbie Stark, PHE Healthcare Public Health Consultant Kevin Elliston: PHE Consultant in Health Improvement

More information

Interactive Voice Response Technology To Prevent Type 2 Diabetes in Cardiac Population

Interactive Voice Response Technology To Prevent Type 2 Diabetes in Cardiac Population Interactive Voice Response Technology To Prevent Type 2 Diabetes in Cardiac Population Overview The University of Ottawa Heart Institute (UOHI) with an annual rate of 6000 admissions is committed to understanding,

More information

Supplementary webappendix

Supplementary webappendix Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Wu Y-T, Fratiglioni L, Matthews FE, et

More information

Steven Allender, Peter Scarborough, Viv Peto and Mike Rayner

Steven Allender, Peter Scarborough, Viv Peto and Mike Rayner 2008 edition Steven Allender, Peter Scarborough, Viv Peto and Mike Rayner British Heart Foundation Health Promotion Research Group Department of Public Health, University of Oxford Jose Leal, Ramon Luengo-Fernandez

More information

ENHANCED REPORTING OF DEATHS AMONG ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLES USING LINKED ADMINISTRATIVE HEALTH DATASETS

ENHANCED REPORTING OF DEATHS AMONG ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLES USING LINKED ADMINISTRATIVE HEALTH DATASETS ENHANCED REPORTING OF DEATHS AMONG ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLES USING LINKED ADMINISTRATIVE HEALTH DATASETS BACKGROUND Improving the health of Aboriginal and Torres Strait Islander peoples

More information